Study: Shingles vaccine is effective for seniors but few get it

04/10/2013 | HealthDay News

An analysis of data from more than 700,000 Medicaid beneficiaries found that the shingles vaccine is effective at reducing the risk of shingles and post-herpetic neuralgia, but only 4% in the study group received it. The vaccine reduced the rate of shingles by 48% and post-herpetic neuralgia by 59% overall. The study appeared in the journal PLoS Medicine.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR